Protalix BioTherapeutics, Inc. (PLX)

Last Closing Price: 3.02 (2026-11-18)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

Protalix BioTherapeutics, Inc. (PLX) had Earnings per Share (EPS) (Diluted) of $0.05 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$21.93M
$3.96M
$7.88M
$14.05M
$17.88M
$4.05M
$0.57M
$4.62M
$4.62M
$3.96M
$3.96M
$3.96M
$3.96M
$4.05M
$4.47M
80.46M
83.59M
$0.05
Earnings per Share (EPS) (Diluted)
$0.05
Balance Sheet Financials
$98.87M
$5.77M
$19.37M
$118.24M
$30.23M
--
$7.46M
$37.69M
$80.55M
$80.55M
$80.55M
82.49M
Cash Flow Statement Financials
$15.53M
$-13.22M
$4.73M
$14.68M
$22.04M
$7.36M
$1.53M
--
--
Fundamental Metrics & Ratios
3.27
--
--
--
--
64.08%
18.46%
18.46%
--
21.08%
18.07%
$13.44M
--
--
--
0.19
0.23
1.58
57.11
4.92%
4.92%
3.35%
4.92%
$0.98
$0.16
$0.19